REAX Stock Analysis: Real Brokerage | NASDAQ
Real Estate Services | NASDAQ, USA | Market Cap: 459m USD | 12M Return: -49% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 7.50M
Qual. Beats: 0
Rev. Trend: 99.4%
Qual. Beats: 0
Warnings
Tailwinds
No distinct edge detected
Seasonality 6 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Real Brokerage Inc. (REAX) is a real estate technology company operating in the United States and Canada, founded in 2014 and headquartered in Miami, Florida. The company provides title, mortgage, and wallet services, along with ancillary offerings such as mortgage origination, title and escrow services, and financial technology and lending products. As a PropTech-focused firm, REAX operates within the real estate sector and aims to streamline traditional brokerage transactions through an integrated, tech-enabled platform that combines agent services with adjacent financial products typically handled by separate providers at closing.
- Agent count growth accelerates transaction volume expansion
- NAR settlement reshapes real estate commission economics
- Title and mortgage services lift per-transaction revenue
| Net Income: -6.56m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.53 > 0.02 and ΔFCF/TA 2.03 > 1.0 |
| NWC/Revenue: 2.18% < 20% (prev 1.13%; Δ 1.06% < -1%) |
| CFO/TA 0.53 > 3% & CFO 83.7m > Net Income -6.56m |
| Net Debt/EBITDA: error (cannot be calculated) |
| Current Ratio: 1.50 > 1.5 & < 3 |
| Outstanding Shares: last quarter (223.7m) vs 12m ago 9.45% < -2% |
| Gross Margin: 8.36% > 18% (prev 9.00%; Δ -0.64% > 0.5%) |
| Asset Turnover: 1.62k% > 50% (prev 1.41k%; Δ 204.9% > 0%) |
| Interest Coverage Ratio: -10.72 > 6 (EBIT TTM -6.49m / Interest Expense TTM 606k) |
| A: 0.29 (Total Current Assets 136.7m - Total Current Liabilities 91.3m) / Total Assets 156.9m |
| B: -0.74 (Retained Earnings -116.3m / Total Assets 156.9m) |
| C: -0.05 (EBIT TTM -6.49m / Avg Total Assets 128.7m) |
| D: 0.72 (Book Value of Equity 65.7m / Total Liabilities 91.3m) |
| Altman-Z'' = -0.10 = B |
| DSRI: 1.38 (Receivables 34.2m/16.8m, Revenue 2.08b/1.42b) |
| GMI: 1.08 (GM 9.00% / 8.36%) |
| AQI: 0.79 (AQ_t 0.11 / AQ_t-1 0.14) |
| SGI: 1.47 (Revenue 2.08b / 1.42b) |
| TATA: -0.58 (NI -6.56m - CFO 83.7m) / TA 156.9m) |
| Beneish M = -2.49 (Cap -4..+1) = BBB |
As of July 14, 2026, the stock is trading at USD 2.07 with a total of 4,907,388 shares traded. Over the past week, the price has changed by -5.91%, over one month by +24.70%, over three months by -19.14% and over the past year by -49.01%.
Current recommended Stop Loss: 1.70 (which is 17.9% or 2.8 ATR below the current price).
Real Brokerage has received a consensus analysts rating of 4.75. Therefore, it is recommended to buy REAX.
- StrongBuy: 3
- Buy: 1
- Hold: 0
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 5.2 | 148.8% |
P/S = 0.2208
P/B = 6.9913
Revenue TTM = 2.08b USD
EBIT TTM = -6.49m USD
EBITDA TTM = -4.37m USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 359.5m USD (459.3m + (null Debt) - CCE 99.7m)
Interest Coverage Ratio = -10.72 (Ebit TTM -6.49m / Interest Expense TTM 606k)
EV/FCF = 4.35x (Enterprise Value 359.5m / FCF TTM 82.7m)
FCF Yield = 22.99% (FCF TTM 82.7m / Enterprise Value 359.5m)
FCF Margin = 3.97% (FCF TTM 82.7m / Revenue TTM 2.08b)
Net Margin = -0.32% (Net Income TTM -6.56m / Revenue TTM 2.08b)
Gross Margin = 8.36% ((Revenue TTM 2.08b - Cost of Revenue TTM 1.91b) / Revenue TTM)
Gross Margin QoQ = 9.05% (prev 7.73%)
Tobins Q-Ratio = 2.29 (Enterprise Value 359.5m / Total Assets 156.9m)
Interest Expense / Debt = unknown (Interest Expense 606k / Debt none)
Taxrate = 21.0% (US federal default 21%)
NOPAT = -5.13m (EBIT -6.49m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 1.50 (Total Current Assets 136.7m / Total Current Liabilities 91.3m)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA -4.37m)
Debt / FCF = unknown (Net Debt none / FCF TTM 82.7m)
Total Stockholder Equity = 55.0m (last 4 quarters mean from totalStockholderEquity)
RoA = -5.10% (Net Income -6.56m / Total Assets 156.9m)
RoE = -11.92% (Net Income TTM -6.56m / Total Stockholder Equity 55.0m)
RoCE = -9.90% (EBIT -6.49m / Capital Employed (Total Assets 156.9m - Current Liab 91.3m))
RoIC = 15.03% (negative operating profit) (NOPAT -5.13m / Invested Capital -34.1m)
WACC = 9.72% (E(459.3m)/V(459.3m) * Re(9.72%) + (debt-free company))
Discount Rate = 9.72% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 86.67 | Cagr: 9.79%
[DCF] Terminal Value 73.67% ; FCFF base≈70.0m ; Y1≈80.2m ; Y5≈118.0m
[DCF] Fair Price = 6.67 (EV 1.43b - Net Debt 0.0 = Equity 1.43b / Shares 214.6m; r=9.72% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: N/A | EPS CAGR: N/A | SUE: 0.43 | # QB: 0
Revenue Correlation: 99.44 | Revenue CAGR: 70.35% | SUE: -0.82 | # QB: 0
EPS current Quarter (2026-06-30): EPS=0.01 | Chg30d=N/A | Revisions=-25% | Analysts=4
EPS next Quarter (2026-09-30): EPS=0.01 | Chg30d=N/A | Revisions=+0% | Analysts=4
EPS current Year (2026-12-31): EPS=-0.02 | Chg30d=N/A | Revisions=-40% | GrowthEPS=+50.0% | GrowthRev=+21.2%
EPS next Year (2027-12-31): EPS=0.03 | Chg30d=-38.10% | Revisions=+40% | GrowthEPS=+230.0% | GrowthRev=+14.4%
[Analyst] Revisions Ratio: -12% (up=2, down=3)